CompanyDrug

Luye Pharma’s Goserelin Acetate Microspheres Approved by NMPA for Prostate Cancer Treatment

Policy / Regulatory

CDE Releases 72nd Batch of Generic Reference Preparations with New Specifications

CompanyDrug

Huadong Medicine’s Liraglutide Biosimilar Gains NMPA Approval for Weight Loss Indication

CompanyDrug

Abbisko Therapeutics’ EGFR Inhibitor ABSK112 Clears FDA for Global Phase I NSCLC Study

CompanyDrug

Jacobio Pharma’s KRAS Inhibitor Glecirasib Advances to Pivotal Pancreatic Cancer Trial

CompanyDrug

InnoCare Pharma Initiates Clinical Trial for TYK2 Inhibitor ICP-488 in Psoriasis Patients

CompanyMedical Device

ZAP-X Gyroscopic Radiosurgery Platform Receives NMPA Approval for Brain Tumor Treatment

CompanyDrug

NMPA Approves Pitolisant for Narcolepsy-Related Excessive Daytime Drowsiness and Cataplexy

CompanyDrug

Ascentage Pharma’s Olverembatinib Gets NMPA Greenlight for Phase III Study in Ph+ ALL

CompanyDrug

Amoytop Biotech’s Pegfilgrastim (Y Shape) Approved for Marketing by NMPA

CompanyDeals

Jacobio Pharma Retakes Global Rights to SHP2 Inhibitors After Terminating AbbVie Agreement

CompanyMedical Device

Helio Genomics’ Sister Company LAMH Wins NMPA Approval for Liver Cancer Test in China